GenScript owns a number of intellectual property rights and technical secrets, including more than 100 patents and over 270 patent applications. As of Q3 2022, GenScript's products and services have been cited by 57,000 peer-reviewed journal articles worldwide. For more information visit genscript.com.
GenScript ProBio has established the integrated innovative biologics CDMO platforms, covering two major service areas: therapeutic antibody-drug and gene & cell therapy. The company is committed to driving innovation and accelerating biologics development from target to market. Visit genscriptprobio.com for additional details.